Check out market updates

Clovis says initial Phase III data is positive for ovarian cancer study

BOULDER — Clovis Oncology Inc. (Nasdaq: CLVS) said the first round of data from a Phase III study of its […]
Source: BizWest

Leave a Reply

Your email address will not be published. Required fields are marked *